MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Change in Account Payables (2015 - 2025)

MetaVia's (MTVA) quarterly Change in Account Payables came in at -$1.5 million in Q4 2025, down 150.69% YoY from $3.0 million in Q4 2024, and down 2363.24% on a QoQ basis from $68000.0 in Q3 2025.

MetaVia (MTVA) Change in Account Payables (2015 - 2025) Analysis & Trends

MetaVia (MTVA) has 11 years of Change in Account Payables data on file, last reported at -$1.5 million in Q4 2025.

  • Quarterly Change in Account Payables fell 150.69% year-over-year to -$1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.8 million (down 192.18% YoY) and the FY2025 annual result came in at -$2.8 million, down 192.18% from the prior year.
  • Change in Account Payables slipped to -$1.5 million in Q4 2025, from $68000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.0 million in Q4 2024 to a low of -$2.1 million in Q1 2021.
  • A 5-year average of -$50600.0 and a median of -$82500.0 in 2022 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2023 — Change in Account Payables jumped 861.11% — and 2025, when it plunged 478.99%.
  • Tracing MTVA's Change in Account Payables over 5 years: stood at $484000.0 in 2021, then tumbled by 165.29% to -$316000.0 in 2022, then tumbled by 267.09% to -$1.2 million in 2023, then soared by 361.72% to $3.0 million in 2024, then sank by 150.69% to -$1.5 million in 2025.
  • The last three Change in Account Payables figures came in at -$1.5 million (Q4 2025), $68000.0 (Q3 2025), and -$523000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 MetaVia 8.72 Mn -3.92 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.54 Mn
Dec 31, 2025 -1.54 Mn
Sep 30, 2025 68,000.00
Sep 30, 2025 68,000.00
Jun 30, 2025 -523,000.00
Jun 30, 2025 -523,000.00
Mar 31, 2025 -825,000.00
Mar 31, 2025 -825,000.00
Dec 31, 2024 3.04 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 -1.37 Mn
Sep 30, 2024 -1.37 Mn
Jun 30, 2024 138,000.00
Jun 30, 2024 138,000.00
Mar 31, 2024 1.26 Mn
Mar 31, 2024 1.26 Mn
Dec 31, 2023 -1.16 Mn
Dec 31, 2023 -1.16 Mn
Sep 30, 2023 1.01 Mn
Sep 30, 2023 1.01 Mn